ANNEXA-4 substudy: Hemostatic efficacy and anti-FXa (Factor Xa) reversal with andexanet alfa in intracranial hemorrhage
Stroke Journal - AHA
AM Demchuk, P Yue, E Zotova, J Nakamya, L Xu, TJ Milling, T Ohara, JN Goldstein, S Middeldorp, P Verhamme, JL Lopez-Sendon, PB Conley, JT Curnutte, JW Eikelboom, M Crowther, SJ Connolly
May 2021
